Management of MDR-TB in resource-poor countries

Int J Tuberc Lung Dis. 1999 Aug;3(8):643-5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Clinical Protocols
  • Cost-Benefit Analysis
  • Developing Countries*
  • Disease Management
  • Humans
  • Methicillin Resistance*
  • Tuberculosis / drug therapy*
  • Tuberculosis / economics

Substances

  • Antitubercular Agents